Skip to main content
Top
Published in: Journal of NeuroVirology 4/2020

Open Access 01-08-2020 | Primary Immunodeficiency | Review

Determinants of neurological syndromes caused by varicella zoster virus (VZV)

Authors: Peter GE Kennedy, Trine H Mogensen

Published in: Journal of NeuroVirology | Issue 4/2020

Login to get access

Abstract

Varicella zoster virus (VZV) is a pathogenic human herpes virus which causes varicella as a primary infection, following which it becomes latent in peripheral autonomic, sensory, and cranial nerve ganglionic neurons from where it may reactivate after decades to cause herpes zoster. VZV reactivation may also cause a wide spectrum of neurological syndromes, in particular, acute encephalitis and vasculopathy. While there is potentially a large number of coding viral mutations that might predispose certain individuals to VZV infections, in practice, a variety of host factors are the main determinants of VZV infection, both disseminated and specifically affecting the nervous system. Host factors include increasing age with diminished cell-mediated immunity to VZV, several primary immunodeficiency syndromes, secondary immunodeficiency syndromes, and drug-induced immunosuppression. In some cases, the molecular immunological basis underlying the increased risk of VZV infections has been defined, in particular, the role of POL III mutations, but in other cases, the mechanisms have yet to be determined. The role of immunization in immunosuppressed individuals as well as its possible efficacy in preventing both generalized and CNS-specific infections will require further investigation to clarify in such patients.
Literature
go back to reference Abdollahpour H, Appaswamy G, Kotlarz D, Diestelhorst J, Beier R, Schaffer AA, Gertz EM, Schambach A, Kreipe HH, Pfeifer D et al (2012) The phenotype of human STK4 deficiency. Blood 119:3450–3457PubMedPubMedCentral Abdollahpour H, Appaswamy G, Kotlarz D, Diestelhorst J, Beier R, Schaffer AA, Gertz EM, Schambach A, Kreipe HH, Pfeifer D et al (2012) The phenotype of human STK4 deficiency. Blood 119:3450–3457PubMedPubMedCentral
go back to reference Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V (2009) RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 10:1065–1072PubMed Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V (2009) RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 10:1065–1072PubMed
go back to reference Abolhassani H, Edwards ES, Ikinciogullari A, Jing H, Borte S, Buggert M, Du L, Matsuda-Lennikov M, Romano R, Caridha R et al (2017) Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency. J Exp Med 214:91–106PubMedPubMedCentral Abolhassani H, Edwards ES, Ikinciogullari A, Jing H, Borte S, Buggert M, Du L, Matsuda-Lennikov M, Romano R, Caridha R et al (2017) Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency. J Exp Med 214:91–106PubMedPubMedCentral
go back to reference Al-Herz W, Essa S (2019) Spectrum of viral infections among primary immunodeficient children: report from a national registry. Front Immunol 10:1231PubMedPubMedCentral Al-Herz W, Essa S (2019) Spectrum of viral infections among primary immunodeficient children: report from a national registry. Front Immunol 10:1231PubMedPubMedCentral
go back to reference Albert MH, Notarangelo LD, Ochs HD (2011) Clinical spectrum, pathophysiology and treatment of the Wiskott-Aldrich syndrome. Curr Opin Hematol 18:42–48PubMed Albert MH, Notarangelo LD, Ochs HD (2011) Clinical spectrum, pathophysiology and treatment of the Wiskott-Aldrich syndrome. Curr Opin Hematol 18:42–48PubMed
go back to reference Alkhairy OK, Perez-Becker R, Driessen GJ, Abolhassani H, van Montfrans J, Borte S, Choo S, Wang N, Tesselaar K, Fang M et al (2015) Novel mutations in TNFRSF7/CD27: clinical, immunologic, and genetic characterization of human CD27 deficiency. J Allergy Clin Immunol 136(703–712):e710 Alkhairy OK, Perez-Becker R, Driessen GJ, Abolhassani H, van Montfrans J, Borte S, Choo S, Wang N, Tesselaar K, Fang M et al (2015) Novel mutations in TNFRSF7/CD27: clinical, immunologic, and genetic characterization of human CD27 deficiency. J Allergy Clin Immunol 136(703–712):e710
go back to reference Antonelli MA, Moreland LW, Brick JE (1991) Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate. Am J Med 90:295–298PubMed Antonelli MA, Moreland LW, Brick JE (1991) Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate. Am J Med 90:295–298PubMed
go back to reference Armangue T, Moris G, Cantarin-Extremera V, Conde CE, Rostasy K, Erro ME, Portilla-Cuenca JC, Turon-Vinas E, Malaga I, Munoz-Cabello B et al (2015) Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology 85:1736–1743PubMedPubMedCentral Armangue T, Moris G, Cantarin-Extremera V, Conde CE, Rostasy K, Erro ME, Portilla-Cuenca JC, Turon-Vinas E, Malaga I, Munoz-Cabello B et al (2015) Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology 85:1736–1743PubMedPubMedCentral
go back to reference Arvin AM, Moffat JF, Sommer M, Oliver S, Che X, Vleck S, Zerboni L, Ku CC (2010) Varicella-zoster virus T cell tropism and the pathogenesis of skin infection. Curr Top Microbiol Immunol 342:189–209PubMedPubMedCentral Arvin AM, Moffat JF, Sommer M, Oliver S, Che X, Vleck S, Zerboni L, Ku CC (2010) Varicella-zoster virus T cell tropism and the pathogenesis of skin infection. Curr Top Microbiol Immunol 342:189–209PubMedPubMedCentral
go back to reference Batisse D, Eliaszewicz M, Zazoun L, Baudrimont M, Pialoux G, Dupont B (1996) Acute retinal necrosis in the course of AIDS: study of 26 cases. AIDS 10:55–60PubMed Batisse D, Eliaszewicz M, Zazoun L, Baudrimont M, Pialoux G, Dupont B (1996) Acute retinal necrosis in the course of AIDS: study of 26 cases. AIDS 10:55–60PubMed
go back to reference Becerra JC, Sieber R, Martinetti G, Costa ST, Meylan P, Bernasconi E (2013) Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study. Int J Infect Dis 17:e529–e534PubMed Becerra JC, Sieber R, Martinetti G, Costa ST, Meylan P, Bernasconi E (2013) Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study. Int J Infect Dis 17:e529–e534PubMed
go back to reference Bernard G, Chouery E, Putorti ML, Tetreault M, Takanohashi A, Carosso G, Clement I, Boespflug-Tanguy O, Rodriguez D, Delague V et al (2011) Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. Am J Hum Genet 89:415–423PubMedPubMedCentral Bernard G, Chouery E, Putorti ML, Tetreault M, Takanohashi A, Carosso G, Clement I, Boespflug-Tanguy O, Rodriguez D, Delague V et al (2011) Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. Am J Hum Genet 89:415–423PubMedPubMedCentral
go back to reference Bezrodnik L, Di Giovanni D, Caldirola MS, Azcoiti ME, Torgerson T, Gaillard MI (2015) Long-term follow-up of STAT5B deficiency in three argentinian patients: clinical and immunological features. J Clin Immunol 35:264–272PubMed Bezrodnik L, Di Giovanni D, Caldirola MS, Azcoiti ME, Torgerson T, Gaillard MI (2015) Long-term follow-up of STAT5B deficiency in three argentinian patients: clinical and immunological features. J Clin Immunol 35:264–272PubMed
go back to reference Birlea M, Arendt G, Orhan E, Schmid DS, Bellini WJ, Schmidt C, Gilden D, Cohrs RJ (2011) Subclinical reactivation of varicella zoster virus in all stages of HIV infection. J Neurol Sci 304:22–24PubMedPubMedCentral Birlea M, Arendt G, Orhan E, Schmid DS, Bellini WJ, Schmidt C, Gilden D, Cohrs RJ (2011) Subclinical reactivation of varicella zoster virus in all stages of HIV infection. J Neurol Sci 304:22–24PubMedPubMedCentral
go back to reference Biron CA, Byron KS, Sullivan JL (1989) Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320:1731–1735PubMed Biron CA, Byron KS, Sullivan JL (1989) Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320:1731–1735PubMed
go back to reference Bode SF, Lehmberg K, Maul-Pavicic A, Vraetz T, Janka G, Stadt UZ, Ehl S (2012) Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Arthritis Res Ther 14:213PubMedPubMedCentral Bode SF, Lehmberg K, Maul-Pavicic A, Vraetz T, Janka G, Stadt UZ, Ehl S (2012) Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Arthritis Res Ther 14:213PubMedPubMedCentral
go back to reference Bourdette D, Gilden D (2012) Fingolimod and multiple sclerosis: four cautionary tales. Neurology 79:1942–1943PubMed Bourdette D, Gilden D (2012) Fingolimod and multiple sclerosis: four cautionary tales. Neurology 79:1942–1943PubMed
go back to reference Bourre B, Lefaucheur R, Ahtoy P, Travers F, Fetter D (2013) Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab. Neurology 81:1966–1967PubMed Bourre B, Lefaucheur R, Ahtoy P, Travers F, Fetter D (2013) Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab. Neurology 81:1966–1967PubMed
go back to reference Burke DG, Kalayjian RC, Vann VR, Madreperla SA, Shick HE, Leonard DG (1997) Polymerase chain reaction detection and clinical significance of varicella-zoster virus in cerebrospinal fluid from human immunodeficiency virus-infected patients. J Infect Dis 176:1080–1084PubMed Burke DG, Kalayjian RC, Vann VR, Madreperla SA, Shick HE, Leonard DG (1997) Polymerase chain reaction detection and clinical significance of varicella-zoster virus in cerebrospinal fluid from human immunodeficiency virus-infected patients. J Infect Dis 176:1080–1084PubMed
go back to reference Buckingham EM, Foley MA, Grose C, Syed NA, Smith ME, Margolis TP, Thurtell MJ, Kardon R (2018) Identification of herpes zoster-associated temporal arteritis among cases of giant cell arteritis. Am J Ophthalmol 187:51–60. Buckingham EM, Foley MA, Grose C, Syed NA, Smith ME, Margolis TP, Thurtell MJ, Kardon R (2018) Identification of herpes zoster-associated temporal arteritis among cases of giant cell arteritis. Am J Ophthalmol 187:51–60.
go back to reference Burmester GR, Rubbert-Roth A, Cantagrel A, Hall S, Leszczynski P, Feldman D, Rangaraj MJ, Roane G, Ludivico C, Lu P et al (2014) A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study). Ann Rheum Dis 73:69–74PubMed Burmester GR, Rubbert-Roth A, Cantagrel A, Hall S, Leszczynski P, Feldman D, Rangaraj MJ, Roane G, Ludivico C, Lu P et al (2014) A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study). Ann Rheum Dis 73:69–74PubMed
go back to reference Cacciapaglia F, Zuccaro C, Iannone F (2015) Varicella-zoster virus infection in rheumatoid arthritis patients in the anti-tumour necrosis factor era. Clin Exp Rheumatol 33:917–923PubMed Cacciapaglia F, Zuccaro C, Iannone F (2015) Varicella-zoster virus infection in rheumatoid arthritis patients in the anti-tumour necrosis factor era. Clin Exp Rheumatol 33:917–923PubMed
go back to reference Carter-Timofte ME, Hansen AF, Christiansen M, Paludan SR, Mogensen TH (2019) Mutations in RNA polymerase III genes and defective DNA sensing in adults with varicella-zoster virus CNS infection. Genes Immun 20:214–223PubMed Carter-Timofte ME, Hansen AF, Christiansen M, Paludan SR, Mogensen TH (2019) Mutations in RNA polymerase III genes and defective DNA sensing in adults with varicella-zoster virus CNS infection. Genes Immun 20:214–223PubMed
go back to reference Carter-Timofte ME, Hansen AF, Mardahl M, Fribourg S, Rapaport F, Zhang SY, Casanova JL, Paludan SR, Christiansen M, Larsen CS, Mogensen TH (2018a) Varicella-zoster virus CNS vasculitis and RNA polymerase III gene mutation in identical twins. Neurol Neuroimmunol Neuroinflamm 7;5(6):e500. https://doi.org/10.1212/NXI.0000000000000500 Carter-Timofte ME, Hansen AF, Mardahl M, Fribourg S, Rapaport F, Zhang SY, Casanova JL, Paludan SR, Christiansen M, Larsen CS, Mogensen TH (2018a) Varicella-zoster virus CNS vasculitis and RNA polymerase III gene mutation in identical twins. Neurol Neuroimmunol Neuroinflamm 7;5(6):e500. https://​doi.​org/​10.​1212/​NXI.​0000000000000500​
go back to reference Carter-Timofte ME, Paludan SR, Mogensen TH (2018b) RNA polymerase III as a gatekeeper to prevent severe VZV infections. Trends Mol Med 24:904–915PubMed Carter-Timofte ME, Paludan SR, Mogensen TH (2018b) RNA polymerase III as a gatekeeper to prevent severe VZV infections. Trends Mol Med 24:904–915PubMed
go back to reference Champlin RE, Gale RP (1984) The early complications of bone marrow transplantation. Semin Hematol 21:101–108PubMed Champlin RE, Gale RP (1984) The early complications of bone marrow transplantation. Semin Hematol 21:101–108PubMed
go back to reference Chanan-Khan A, Sonneveld P, Schuster MW, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, Neuwirth R, Anderson KC, Richardson PG (2008) Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study. J Clin Oncol 26:4784–4790PubMed Chanan-Khan A, Sonneveld P, Schuster MW, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, Neuwirth R, Anderson KC, Richardson PG (2008) Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study. J Clin Oncol 26:4784–4790PubMed
go back to reference Chiang JJ, Sparrer KMJ, van Gent M, Lassig C, Huang T, Osterrieder N, Hopfner KP, Gack MU (2018) Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity. Nat Immunol 19:53–62PubMed Chiang JJ, Sparrer KMJ, van Gent M, Lassig C, Huang T, Osterrieder N, Hopfner KP, Gack MU (2018) Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity. Nat Immunol 19:53–62PubMed
go back to reference Chiu YH, Macmillan JB, Chen ZJ (2009) RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138:576–591PubMedPubMedCentral Chiu YH, Macmillan JB, Chen ZJ (2009) RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138:576–591PubMedPubMedCentral
go back to reference Cinque P, Vago L, Dahl H, Brytting M, Terreni MR, Fornara C, Racca S, Castagna A, Monforte AD, Wahren B, Lazzarin A, Linde A (1996) Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 10:951–958PubMed Cinque P, Vago L, Dahl H, Brytting M, Terreni MR, Fornara C, Racca S, Castagna A, Monforte AD, Wahren B, Lazzarin A, Linde A (1996) Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 10:951–958PubMed
go back to reference Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, Aradhye S, Kappos L, TRANSFORMS Study Group (2010) Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 362:402–415PubMed Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, Aradhye S, Kappos L, TRANSFORMS Study Group (2010) Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 362:402–415PubMed
go back to reference Colombel JF (2018) Herpes zoster in patients receiving JAK inhibitors for ulcerative colitis: mechanism, epidemiology, management, and prevention. Inflamm Bowel Dis 24:2173–2182PubMedPubMedCentral Colombel JF (2018) Herpes zoster in patients receiving JAK inhibitors for ulcerative colitis: mechanism, epidemiology, management, and prevention. Inflamm Bowel Dis 24:2173–2182PubMedPubMedCentral
go back to reference Corti M, Villafane MF, Vittar N, Banco MC, Priarone M, Mammana L, Gilardi L (2015) Meningoencephalitis due to varicella zoster virus in aids patients. Report of eleven cases and review of the literature. Rev Inst Med Trop Sao Paulo 57:505–508PubMedPubMedCentral Corti M, Villafane MF, Vittar N, Banco MC, Priarone M, Mammana L, Gilardi L (2015) Meningoencephalitis due to varicella zoster virus in aids patients. Report of eleven cases and review of the literature. Rev Inst Med Trop Sao Paulo 57:505–508PubMedPubMedCentral
go back to reference Cottineau J, Kottemann MC, Lach FP, Kang YH, Vely F, Deenick EK, Lazarov T, Gineau L, Wang Y, Farina A et al (2017) Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest 127:1991–2006PubMedPubMedCentral Cottineau J, Kottemann MC, Lach FP, Kang YH, Vely F, Deenick EK, Lazarov T, Gineau L, Wang Y, Farina A et al (2017) Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest 127:1991–2006PubMedPubMedCentral
go back to reference Crow YJ (2011) Type I interferonopathies: a novel set of inborn errors of immunity. Ann N Y Acad Sci 1238:91–98PubMed Crow YJ (2011) Type I interferonopathies: a novel set of inborn errors of immunity. Ann N Y Acad Sci 1238:91–98PubMed
go back to reference Cui Y, Keles S, Charbonnier LM, Jule AM, Henderson L, Celik SC, Reisli I, Shen C, Xie WJ, Schmitz-Abe K et al (2020) Combined immunodeficiency caused by a loss-of-function mutation in DNA polymerase delta 1. J Allergy Clin Immunol 145(391–401):e398 Cui Y, Keles S, Charbonnier LM, Jule AM, Henderson L, Celik SC, Reisli I, Shen C, Xie WJ, Schmitz-Abe K et al (2020) Combined immunodeficiency caused by a loss-of-function mutation in DNA polymerase delta 1. J Allergy Clin Immunol 145(391–401):e398
go back to reference De Broucker T, Mailles A, Chabrier S, Morand P, Stahl JP, Steering C, investigators, g (2012) Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect 18:808–819PubMed De Broucker T, Mailles A, Chabrier S, Morand P, Stahl JP, Steering C, investigators, g (2012) Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect 18:808–819PubMed
go back to reference Del Castillo M, Romero FA, Arguello E, Kyi C, Postow MA, Redelman-Sidi G (2016) The spectrum of serious infections among patients receiving immune checkpoint blockade for the treatment of melanoma. Clin Infect Dis 63:1490–1493PubMedPubMedCentral Del Castillo M, Romero FA, Arguello E, Kyi C, Postow MA, Redelman-Sidi G (2016) The spectrum of serious infections among patients receiving immune checkpoint blockade for the treatment of melanoma. Clin Infect Dis 63:1490–1493PubMedPubMedCentral
go back to reference Dobbs K, Dominguez Conde C, Zhang SY, Parolini S, Audry M, Chou J, Haapaniemi E, Keles S, Bilic I, Okada S et al (2015) Inherited DOCK2 deficiency in patients with early-onset invasive infections. N Engl J Med 372:2409–2422PubMedPubMedCentral Dobbs K, Dominguez Conde C, Zhang SY, Parolini S, Audry M, Chou J, Haapaniemi E, Keles S, Bilic I, Okada S et al (2015) Inherited DOCK2 deficiency in patients with early-onset invasive infections. N Engl J Med 372:2409–2422PubMedPubMedCentral
go back to reference Duncan CJ, Hambleton S (2015) Varicella zoster virus immunity: a primer. J Inf Secur 71(Suppl 1):S47–S53 Duncan CJ, Hambleton S (2015) Varicella zoster virus immunity: a primer. J Inf Secur 71(Suppl 1):S47–S53
go back to reference Dupuis S, Jouanguy E, Al-Hajjar S, Fieschi C, Al-Mohsen IZ, Al-Jumaah S, Yang K, Chapgier A, Eidenschenk C, Eid P et al (2003) Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet 33:388–391PubMed Dupuis S, Jouanguy E, Al-Hajjar S, Fieschi C, Al-Mohsen IZ, Al-Jumaah S, Yang K, Chapgier A, Eidenschenk C, Eid P et al (2003) Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet 33:388–391PubMed
go back to reference Eyal O, Flaschner M, Ben Yehuda A, Rund D (2017) Varicella-zoster virus meningoencephalitis in a patient treated with ruxolitinib. Am J Hematol 92:E74–E75PubMed Eyal O, Flaschner M, Ben Yehuda A, Rund D (2017) Varicella-zoster virus meningoencephalitis in a patient treated with ruxolitinib. Am J Hematol 92:E74–E75PubMed
go back to reference Fine AJ, Sorbello A, Kortepeter C, Scarazzini L (2013) Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patients. Clin Infect Dis 57:849–852PubMed Fine AJ, Sorbello A, Kortepeter C, Scarazzini L (2013) Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patients. Clin Infect Dis 57:849–852PubMed
go back to reference Fischer A, Notarangelo LD, Neven B, Cavazzana M, Puck JM (2015) Severe combined immunodeficiencies and related disorders. Nat Rev Dis Primers 1:15061PubMed Fischer A, Notarangelo LD, Neven B, Cavazzana M, Puck JM (2015) Severe combined immunodeficiencies and related disorders. Nat Rev Dis Primers 1:15061PubMed
go back to reference Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Langan SM (2014) Quantification of risk factors for herpes zoster: population based case-control study. BMJ 348:g2911PubMedPubMedCentral Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Langan SM (2014) Quantification of risk factors for herpes zoster: population based case-control study. BMJ 348:g2911PubMedPubMedCentral
go back to reference Franco-Paredes C, Bellehemeur T, Merchant A, Sanghi P, DiazGranados C, Rimland D (2002) Aseptic meningitis and optic neuritis preceding varicella-zoster progressive outer retinal necrosis in a patient with AIDS. AIDS 16:1045–1049PubMed Franco-Paredes C, Bellehemeur T, Merchant A, Sanghi P, DiazGranados C, Rimland D (2002) Aseptic meningitis and optic neuritis preceding varicella-zoster progressive outer retinal necrosis in a patient with AIDS. AIDS 16:1045–1049PubMed
go back to reference Furie R, Khamashta M, Merrill JT, Werth VP, Kalunian K, Brohawn P, Illei GG, Drappa J, Wang L, Yoo S, for the CD1013 Study Investigators (2017) Anifrolumab, an anti-interferon-alpha receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus. Arthritis Rheum 69:376–386 Furie R, Khamashta M, Merrill JT, Werth VP, Kalunian K, Brohawn P, Illei GG, Drappa J, Wang L, Yoo S, for the CD1013 Study Investigators (2017) Anifrolumab, an anti-interferon-alpha receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus. Arthritis Rheum 69:376–386
go back to reference Galindez OA, Sabates NR, Whitacre MM, Sabates FN (1996) Rapidly progressive outer retinal necrosis caused by varicella zoster virus in a patient infected with human immunodeficiency virus. Clin Infect Dis 22:149–151PubMed Galindez OA, Sabates NR, Whitacre MM, Sabates FN (1996) Rapidly progressive outer retinal necrosis caused by varicella zoster virus in a patient infected with human immunodeficiency virus. Clin Infect Dis 22:149–151PubMed
go back to reference Garnett GP, Grenfell BT (1992) The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster. Epidemiol Infect 108:513–528PubMedPubMedCentral Garnett GP, Grenfell BT (1992) The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster. Epidemiol Infect 108:513–528PubMedPubMedCentral
go back to reference Garry EM, Delaney A, Anderson HA, Sirinathsinghji EC, Clapp RH, Martin WJ, Kinchington PR, Krah DL, Abbadie C, Fleetwood-Walker SM (2005) Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioural reflex sensitisation that is blocked by gabapentin orsodium channel blocking drugs. Pain 118:97–111PubMed Garry EM, Delaney A, Anderson HA, Sirinathsinghji EC, Clapp RH, Martin WJ, Kinchington PR, Krah DL, Abbadie C, Fleetwood-Walker SM (2005) Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioural reflex sensitisation that is blocked by gabapentin orsodium channel blocking drugs. Pain 118:97–111PubMed
go back to reference Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, Grose C, Hambleton S, Kennedy PG, Oxman MN et al (2015) Varicella zoster virus infection. Nat Rev Dis Primers 1:15016PubMedPubMedCentral Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, Grose C, Hambleton S, Kennedy PG, Oxman MN et al (2015) Varicella zoster virus infection. Nat Rev Dis Primers 1:15016PubMedPubMedCentral
go back to reference Gilden D, Cohrs RJ, Mahalingam R, Nagel MA (2009) Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 8:731–740PubMedPubMedCentral Gilden D, Cohrs RJ, Mahalingam R, Nagel MA (2009) Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 8:731–740PubMedPubMedCentral
go back to reference Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ (2000) Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342:635–645PubMed Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ (2000) Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342:635–645PubMed
go back to reference Gilden D, White T, Khmeleva N, Heintzman A, Choe A, Boyer PJ, Grose C, Carpenter JE, Rempel A, Bos N, Kandasamy B, Lear-Kaul K, Holmes DB, Bennett JL, Cohrs RJ, Mahalingam R, Mandava N, Eberhart CG, Bockelman B, Poppiti RJ, Tamhankar MA, Fogt F, Amato M, Wood E, Durairaj V, Rasmussen S, Petursdottir V, Pollak L, Mendlovic S, Chatelain D, Keyvani K, Brueck W, Nagel MA (2015) Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology 84:1948–1955PubMedPubMedCentral Gilden D, White T, Khmeleva N, Heintzman A, Choe A, Boyer PJ, Grose C, Carpenter JE, Rempel A, Bos N, Kandasamy B, Lear-Kaul K, Holmes DB, Bennett JL, Cohrs RJ, Mahalingam R, Mandava N, Eberhart CG, Bockelman B, Poppiti RJ, Tamhankar MA, Fogt F, Amato M, Wood E, Durairaj V, Rasmussen S, Petursdottir V, Pollak L, Mendlovic S, Chatelain D, Keyvani K, Brueck W, Nagel MA (2015) Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology 84:1948–1955PubMedPubMedCentral
go back to reference Gilden DH, Wright RR, Schneck SA, Gwaltney JM Jr, Mahalingam R (1994) Zoster sine herpete, a clinical variant. Ann Neurol 35:530–533PubMed Gilden DH, Wright RR, Schneck SA, Gwaltney JM Jr, Mahalingam R (1994) Zoster sine herpete, a clinical variant. Ann Neurol 35:530–533PubMed
go back to reference Gineau L, Cognet C, Kara N, Lach FP, Dunne J, Veturi U, Picard C, Trouillet C, Eidenschenk C, Aoufouchi S, Alcaïs A, Smith O, Geissmann F, Feighery C, Abel L, Smogorzewska A, Stillman B, Vivier E, Casanova JL, Jouanguy E (2012) Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. J Clin Invest 122:821–832PubMedPubMedCentral Gineau L, Cognet C, Kara N, Lach FP, Dunne J, Veturi U, Picard C, Trouillet C, Eidenschenk C, Aoufouchi S, Alcaïs A, Smith O, Geissmann F, Feighery C, Abel L, Smogorzewska A, Stillman B, Vivier E, Casanova JL, Jouanguy E (2012) Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. J Clin Invest 122:821–832PubMedPubMedCentral
go back to reference Gnann JW Jr (2002) Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis 186(Suppl 1):S91–S98PubMed Gnann JW Jr (2002) Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis 186(Suppl 1):S91–S98PubMed
go back to reference Gray F, Belec L, Lescs MC, Chretien F, Ciardi A, Hassine D, Flament-Saillour M, de Truchis P, Clair B, Scaravilli F (1994) Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain 117(Pt 5):987–999PubMed Gray F, Belec L, Lescs MC, Chretien F, Ciardi A, Hassine D, Flament-Saillour M, de Truchis P, Clair B, Scaravilli F (1994) Varicella-zoster virus infection of the central nervous system in the acquired immune deficiency syndrome. Brain 117(Pt 5):987–999PubMed
go back to reference Harigai M (2019) Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis. Rheumatology (Oxford) 58:i34–i42 Harigai M (2019) Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis. Rheumatology (Oxford) 58:i34–i42
go back to reference Heusinkveld LE, Yim E, Yang A, Azani AB, Liu Q, Gao JL, McDermott DH, Murphy PM (2017) Pathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency. Expert Opin Orphan Drugs 5:813–825PubMedPubMedCentral Heusinkveld LE, Yim E, Yang A, Azani AB, Liu Q, Gao JL, McDermott DH, Murphy PM (2017) Pathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency. Expert Opin Orphan Drugs 5:813–825PubMedPubMedCentral
go back to reference Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, Patel SY, Frucht DM, Vinh DC, Auth RD, Freeman AF, Olivier KN, Uzel G, Zerbe CS, Spalding C, Pittaluga S, Raffeld M, Kuhns DB, Ding L, Paulson ML, Marciano BE, Gea-Banacloche JC, Orange JS, Cuellar-Rodriguez J, Hickstein DD, Holland SM (2011) Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118:2653–2655PubMedPubMedCentral Hsu AP, Sampaio EP, Khan J, Calvo KR, Lemieux JE, Patel SY, Frucht DM, Vinh DC, Auth RD, Freeman AF, Olivier KN, Uzel G, Zerbe CS, Spalding C, Pittaluga S, Raffeld M, Kuhns DB, Ding L, Paulson ML, Marciano BE, Gea-Banacloche JC, Orange JS, Cuellar-Rodriguez J, Hickstein DD, Holland SM (2011) Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118:2653–2655PubMedPubMedCentral
go back to reference Issa NP, Hentati A (2015) VZV encephalitis that developed in an immunized patient during fingolimod therapy. Neurology 84:99–100PubMed Issa NP, Hentati A (2015) VZV encephalitis that developed in an immunized patient during fingolimod therapy. Neurology 84:99–100PubMed
go back to reference Jemsek J, Greenberg SB, Taber L, Harvey D, Gershon A, Couch RB (1983) Herpes zoster-associated encephalitis: clinicopathologic report of 12 cases and review of the literature. Medicine (Baltimore) 162(2):81–97 Jemsek J, Greenberg SB, Taber L, Harvey D, Gershon A, Couch RB (1983) Herpes zoster-associated encephalitis: clinicopathologic report of 12 cases and review of the literature. Medicine (Baltimore) 162(2):81–97
go back to reference Kennedy PGE (1987) Neurological complications of varicella-zoster virus infections. In: Kennedy PGE, Johnson RT (eds) Infections of the Nervous System. Butterworths, pp 177–208 Kennedy PGE (1987) Neurological complications of varicella-zoster virus infections. In: Kennedy PGE, Johnson RT (eds) Infections of the Nervous System. Butterworths, pp 177–208
go back to reference Kennedy PGE (1988) Neurological complications of human immunodeficiency virus infection. Postgrad Med J 64:180–187 Kennedy PGE (1988) Neurological complications of human immunodeficiency virus infection. Postgrad Med J 64:180–187
go back to reference Kennedy PGE (2011) Zoster sine herpete: it would be rash to ignore it. Neurology 76:416–7 Kennedy PGE (2011) Zoster sine herpete: it would be rash to ignore it. Neurology 76:416–7
go back to reference Kennedy PGE, Grinfeld E, Esiri M (2003) Absence of detection of varicella-zoster virus infection in temporal artery biopsies from patients with giant cell arteritis. J Neurol Sci 215:27–29PubMed Kennedy PGE, Grinfeld E, Esiri M (2003) Absence of detection of varicella-zoster virus infection in temporal artery biopsies from patients with giant cell arteritis. J Neurol Sci 215:27–29PubMed
go back to reference Kennedy PGE, Grinfeld E, Gow JW (1998) Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc Natl Acad Sci U S A 95:4658–4662PubMedPubMedCentral Kennedy PGE, Grinfeld E, Gow JW (1998) Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc Natl Acad Sci U S A 95:4658–4662PubMedPubMedCentral
go back to reference Kim JA, Park SK, Seo SW, Lee CH, Shin OS (2017) STING is involved in antiviral immune response against VZV infection via the induction of type I and III IFN pathways. J Invest Dermatol 137:2101–2109PubMed Kim JA, Park SK, Seo SW, Lee CH, Shin OS (2017) STING is involved in antiviral immune response against VZV infection via the induction of type I and III IFN pathways. J Invest Dermatol 137:2101–2109PubMed
go back to reference Kleinschmidt-DeMasters BK, Amlie-Lefond C, Gilden DH (1996) The patterns of varicella zoster virus encephalitis. Hum Pathol 27:927–938PubMed Kleinschmidt-DeMasters BK, Amlie-Lefond C, Gilden DH (1996) The patterns of varicella zoster virus encephalitis. Hum Pathol 27:927–938PubMed
go back to reference Konig C, Kleber M, Reinhardt H, Knop S, Wasch R, Engelhardt M (2014) Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients. Ann Hematol 93:479–484PubMed Konig C, Kleber M, Reinhardt H, Knop S, Wasch R, Engelhardt M (2014) Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients. Ann Hematol 93:479–484PubMed
go back to reference Kreins AY, Ciancanelli MJ, Okada S, Kong XF, Ramirez-Alejo N, Kilic SS, El Baghdadi J, Nonoyama S, Mahdaviani SA, Ailal F et al (2015) Human TYK2 deficiency: mycobacterial and viral infections without hyper-IgE syndrome. J Exp Med 212:1641–1662PubMedPubMedCentral Kreins AY, Ciancanelli MJ, Okada S, Kong XF, Ramirez-Alejo N, Kilic SS, El Baghdadi J, Nonoyama S, Mahdaviani SA, Ailal F et al (2015) Human TYK2 deficiency: mycobacterial and viral infections without hyper-IgE syndrome. J Exp Med 212:1641–1662PubMedPubMedCentral
go back to reference Lim HK, Seppanen M, Hautala T, Ciancanelli MJ, Itan Y, Lafaille FG, Dell W, Lorenzo L, Byun M, Pauwels E, Ronnelid Y, Cai X, Boucherit S, Jouanguy E, Paetau A, Lebon P, Rozenberg F, Tardieu M, Abel L, Yildiran A, Vergison A, Roivainen R, Etzioni A, Tienari PJ, Casanova JL, Zhang SY (2014) TLR3 deficiency in herpes simplex encephalitis: high allelic heterogeneity and recurrence risk. Neurology 83:1888–1897PubMedPubMedCentral Lim HK, Seppanen M, Hautala T, Ciancanelli MJ, Itan Y, Lafaille FG, Dell W, Lorenzo L, Byun M, Pauwels E, Ronnelid Y, Cai X, Boucherit S, Jouanguy E, Paetau A, Lebon P, Rozenberg F, Tardieu M, Abel L, Yildiran A, Vergison A, Roivainen R, Etzioni A, Tienari PJ, Casanova JL, Zhang SY (2014) TLR3 deficiency in herpes simplex encephalitis: high allelic heterogeneity and recurrence risk. Neurology 83:1888–1897PubMedPubMedCentral
go back to reference Liu JZ, Brown P, Tselis A (2005) Unilateral retrobulbar optic neuritis due to varicella zoster virus in a patient with AIDS: a case report and review of the literature. J Neurol Sci 237:97–101PubMed Liu JZ, Brown P, Tselis A (2005) Unilateral retrobulbar optic neuritis due to varicella zoster virus in a patient with AIDS: a case report and review of the literature. J Neurol Sci 237:97–101PubMed
go back to reference Longfield JN, Winn RE, Gibson RL, Juchau SV, Hoffman PV (1990) Varicella outbreaks in Army recruits from Puerto Rico. Varicella susceptibility in a population from the tropics. Arch Intern Med 150:970–973PubMed Longfield JN, Winn RE, Gibson RL, Juchau SV, Hoffman PV (1990) Varicella outbreaks in Army recruits from Puerto Rico. Varicella susceptibility in a population from the tropics. Arch Intern Med 150:970–973PubMed
go back to reference Luby JP, Ramirez-Ronda C, Rinner S, Hull A, Vergne-Marini P (1977) A longitudinal study of varicella-zoster virus infections in renal transplant recipients. J Infect Dis 135:659–663PubMed Luby JP, Ramirez-Ronda C, Rinner S, Hull A, Vergne-Marini P (1977) A longitudinal study of varicella-zoster virus infections in renal transplant recipients. J Infect Dis 135:659–663PubMed
go back to reference Manian FA, Kindred M, Fulling KH (1995) Chronic varicella-zoster virus myelitis without cutaneous eruption in a patient with AIDS: report of a fatal case. Clin Infect Dis 21:986–988PubMed Manian FA, Kindred M, Fulling KH (1995) Chronic varicella-zoster virus myelitis without cutaneous eruption in a patient with AIDS: report of a fatal case. Clin Infect Dis 21:986–988PubMed
go back to reference Marra F, Lo E, Kalashnikov V, Richardson K (2016) Risk of herpes zoster in individuals on biologics, disease-modifying antirheumatic drugs, and/or corticosteroids for autoimmune diseases: a systematic review and meta-analysis. Open Forum Infect Dis 3:ofw205. https://doi.org/10.1093/ofid/ofw205 Marra F, Lo E, Kalashnikov V, Richardson K (2016) Risk of herpes zoster in individuals on biologics, disease-modifying antirheumatic drugs, and/or corticosteroids for autoimmune diseases: a systematic review and meta-analysis. Open Forum Infect Dis 3:ofw205. https://​doi.​org/​10.​1093/​ofid/​ofw205
go back to reference McLean-Tooke A, Aldridge C, Waugh S, Spickett GP, Kay L (2009) Methotrexate, rheumatoid arthritis and infection risk: what is the evidence? Rheumatology (Oxford) 48:867–871 McLean-Tooke A, Aldridge C, Waugh S, Spickett GP, Kay L (2009) Methotrexate, rheumatoid arthritis and infection risk: what is the evidence? Rheumatology (Oxford) 48:867–871
go back to reference Melbye M, Grossman RJ, Goedert JJ, Eyster ME, Biggar RJ (1987) Risk of AIDS after herpes zoster. Lancet 1:728–731PubMed Melbye M, Grossman RJ, Goedert JJ, Eyster ME, Biggar RJ (1987) Risk of AIDS after herpes zoster. Lancet 1:728–731PubMed
go back to reference Mogensen TH (2018) IRF and STAT transcription factors - from basic biology to roles in infection, protective immunity, and primary immunodeficiencies. Front Immunol 9:3047PubMed Mogensen TH (2018) IRF and STAT transcription factors - from basic biology to roles in infection, protective immunity, and primary immunodeficiencies. Front Immunol 9:3047PubMed
go back to reference Nagel MA, Forghani B, Mahalingam R, Wellish MC, Cohrs RJ, Russman AN, Katzan I, Lin R, Gardner CJ, Gilden DH (2007) The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology 68:1069–1073PubMed Nagel MA, Forghani B, Mahalingam R, Wellish MC, Cohrs RJ, Russman AN, Katzan I, Lin R, Gardner CJ, Gilden DH (2007) The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology 68:1069–1073PubMed
go back to reference Nagel MA, Gilden DH (2007) The protean neurologic manifestations of varicella-zoster virus. Cleve Clin J Med 74:489–504PubMed Nagel MA, Gilden DH (2007) The protean neurologic manifestations of varicella-zoster virus. Cleve Clin J Med 74:489–504PubMed
go back to reference Nagel MA, White T, Khmeleva N, Rempel A, Boyer PJ, Bennett JL, Haller A, Lear-Kaul K, Kandasmy B, Amato M, Wood E, Durairaj V, Fogt F, Tamhankar MA, Grossniklaus HE, Poppiti RJ, Bockelman B, Keyvani K, Pollak L, Mendlovic S, Fowkes M, Eberhart CG, Buttmann M, Toyka KV, Meyer-ter-Vehn T, Petursdottir V, Gilden D (2015) Analysis of varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis. JAMA Neurol 72:1281–1287PubMedPubMedCentral Nagel MA, White T, Khmeleva N, Rempel A, Boyer PJ, Bennett JL, Haller A, Lear-Kaul K, Kandasmy B, Amato M, Wood E, Durairaj V, Fogt F, Tamhankar MA, Grossniklaus HE, Poppiti RJ, Bockelman B, Keyvani K, Pollak L, Mendlovic S, Fowkes M, Eberhart CG, Buttmann M, Toyka KV, Meyer-ter-Vehn T, Petursdottir V, Gilden D (2015) Analysis of varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis. JAMA Neurol 72:1281–1287PubMedPubMedCentral
go back to reference Nagasako EM, Johnson RW, Griffin DR, Elpern DJ, Dworkin RH (2003) Geographic and racial aspects of herpes zoster. J Med Virol 70(Suppl 1):S20–S23PubMed Nagasako EM, Johnson RW, Griffin DR, Elpern DJ, Dworkin RH (2003) Geographic and racial aspects of herpes zoster. J Med Virol 70(Suppl 1):S20–S23PubMed
go back to reference Newsome SD, Nath A (2009) Varicella-zoster virus vasculopathy and central nervous system immune reconstitution inflammatory syndrome with human immunodeficiency virus infection treated with steroids. J Neuro-Oncol 15:288–291 Newsome SD, Nath A (2009) Varicella-zoster virus vasculopathy and central nervous system immune reconstitution inflammatory syndrome with human immunodeficiency virus infection treated with steroids. J Neuro-Oncol 15:288–291
go back to reference Ogunjimi B, Zhang SY, Sorensen KB, Skipper KA, Carter-Timofte M, Kerner G, Luecke S, Prabakaran T, Cai Y, Meester J et al (2017) Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections. J Clin Invest 127:3543–3556PubMedPubMedCentral Ogunjimi B, Zhang SY, Sorensen KB, Skipper KA, Carter-Timofte M, Kerner G, Luecke S, Prabakaran T, Cai Y, Meester J et al (2017) Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections. J Clin Invest 127:3543–3556PubMedPubMedCentral
go back to reference Ostrowski RA, Metgud S, Tehrani R, Walter M, Jay WM (2019) Varicella zoster virus in giant cell arteritis: a review of current medical literature. Neuro-Ophthalmology 43(3):159–170PubMedPubMedCentral Ostrowski RA, Metgud S, Tehrani R, Walter M, Jay WM (2019) Varicella zoster virus in giant cell arteritis: a review of current medical literature. Neuro-Ophthalmology 43(3):159–170PubMedPubMedCentral
go back to reference Park S, Leymarie V, Agbalika F, Galicier L, Oksenhendler E, Sigaux F, Noguera ME (2003) Varicella-zoster viral meningitis mimicking lymphoma. Leuk Lymphoma 44:1793–1795PubMed Park S, Leymarie V, Agbalika F, Galicier L, Oksenhendler E, Sigaux F, Noguera ME (2003) Varicella-zoster viral meningitis mimicking lymphoma. Leuk Lymphoma 44:1793–1795PubMed
go back to reference Picard C, McCarl CA, Papolos A, Khalil S, Luthy K, Hivroz C, LeDeist F, Rieux-Laucat F, Rechavi G, Rao A et al (2009) STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med 360:1971–1980PubMedPubMedCentral Picard C, McCarl CA, Papolos A, Khalil S, Luthy K, Hivroz C, LeDeist F, Rieux-Laucat F, Rechavi G, Rao A et al (2009) STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med 360:1971–1980PubMedPubMedCentral
go back to reference Pourchet A, Modrek AS, Placantonakis DG, Mohr I, Wilson AC (2017) Modeling HSV-1 latency in human embryonic stem cell-derived neurons. Pathogens 6(2):24 Pourchet A, Modrek AS, Placantonakis DG, Mohr I, Wilson AC (2017) Modeling HSV-1 latency in human embryonic stem cell-derived neurons. Pathogens 6(2):24
go back to reference Prader S, Felber M, Volkmer B, Truck J, Schwieger-Briel A, Theiler M, Weibel L, Hambleton S, Seipel K, Vavassori S et al (2018) Life-threatening primary varicella zoster virus infection with hemophagocytic lymphohistiocytosis-like disease in GATA2 haploinsufficiency accompanied by expansion of double negative T-lymphocytes. Front Immunol 9:2766PubMedPubMedCentral Prader S, Felber M, Volkmer B, Truck J, Schwieger-Briel A, Theiler M, Weibel L, Hambleton S, Seipel K, Vavassori S et al (2018) Life-threatening primary varicella zoster virus infection with hemophagocytic lymphohistiocytosis-like disease in GATA2 haploinsufficiency accompanied by expansion of double negative T-lymphocytes. Front Immunol 9:2766PubMedPubMedCentral
go back to reference Ratchford JN, Costello K, Reich DS, Calabresi PA (2012) Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod. Neurology 79:2002–2004PubMedPubMedCentral Ratchford JN, Costello K, Reich DS, Calabresi PA (2012) Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod. Neurology 79:2002–2004PubMedPubMedCentral
go back to reference Ravell JC, Matsuda-Lennikov M, Chauvin SD, Zou J, Biancalana M, Deeb SJ, Price S, Su HC, Notarangelo G, Jiang P, Morawski A, Kanellopoulou C, Binder K, Mukherjee R, Anibal JT, Sellers B, Zheng L, He T, George AB, Pittaluga S, Powers A, Kleiner DE, Kapuria D, Ghany M, Hunsberger S, Cohen JI, Uzel G, Bergerson J, Wolfe L, Toro C, Gahl W, Folio LR, Matthews H, Angelus P, Chinn IK, Orange JS, Trujillo-Vargas CM, Franco JL, Orrego-Arango J, Gutiérrez-Hincapié S, Patel NC, Raymond K, Patiroglu T, Unal E, Karakukcu M, Day AG, Mehta P, Masutani E, de Ravin SS, Malech HL, Altan-Bonnet G, Rao VK, Mann M, Lenardo MJ (2020) Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease. J Clin Invest 130:507–522PubMed Ravell JC, Matsuda-Lennikov M, Chauvin SD, Zou J, Biancalana M, Deeb SJ, Price S, Su HC, Notarangelo G, Jiang P, Morawski A, Kanellopoulou C, Binder K, Mukherjee R, Anibal JT, Sellers B, Zheng L, He T, George AB, Pittaluga S, Powers A, Kleiner DE, Kapuria D, Ghany M, Hunsberger S, Cohen JI, Uzel G, Bergerson J, Wolfe L, Toro C, Gahl W, Folio LR, Matthews H, Angelus P, Chinn IK, Orange JS, Trujillo-Vargas CM, Franco JL, Orrego-Arango J, Gutiérrez-Hincapié S, Patel NC, Raymond K, Patiroglu T, Unal E, Karakukcu M, Day AG, Mehta P, Masutani E, de Ravin SS, Malech HL, Altan-Bonnet G, Rao VK, Mann M, Lenardo MJ (2020) Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease. J Clin Invest 130:507–522PubMed
go back to reference Rodenburg EM, Vermeij FH, van den Bent MJ, Zuetenhorst JM (2017) Varicella zoster virus encephalitis in a patient with a solid carcinoma: a case report. J Neurol 264:1281–1283PubMed Rodenburg EM, Vermeij FH, van den Bent MJ, Zuetenhorst JM (2017) Varicella zoster virus encephalitis in a patient with a solid carcinoma: a case report. J Neurol 264:1281–1283PubMed
go back to reference Roesler J, Kofink B, Wendisch J, Heyden S, Paul D, Friedrich W, Casanova JL, Leupold W, Gahr M, Rosen-Wolff A (1999) Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp Hematol 27:1368–1374PubMed Roesler J, Kofink B, Wendisch J, Heyden S, Paul D, Friedrich W, Casanova JL, Leupold W, Gahr M, Rosen-Wolff A (1999) Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp Hematol 27:1368–1374PubMed
go back to reference Sabry A, Hauk PJ, Jing H, Su HC, Stence NV, Mirsky DM, Nagel MA, Abbott JK, Dragone LL, Armstrong-Wells J, Curtis DJ, Cohrs R, Schmid DS, Gilden D, Gelfand EW (2014) Vaccine strain varicella-zoster virus-induced central nervous system vasculopathy as the presenting feature of DOCK8 deficiency. J Allergy Clin Immunol 133:1225–1227PubMedPubMedCentral Sabry A, Hauk PJ, Jing H, Su HC, Stence NV, Mirsky DM, Nagel MA, Abbott JK, Dragone LL, Armstrong-Wells J, Curtis DJ, Cohrs R, Schmid DS, Gilden D, Gelfand EW (2014) Vaccine strain varicella-zoster virus-induced central nervous system vasculopathy as the presenting feature of DOCK8 deficiency. J Allergy Clin Immunol 133:1225–1227PubMedPubMedCentral
go back to reference Saitsu H, Osaka H, Sasaki M, Takanashi J, Hamada K, Yamashita A, Shibayama H, Shiina M, Kondo Y, Nishiyama K, Tsurusaki Y, Miyake N, Doi H, Ogata K, Inoue K, Matsumoto N (2011) Mutations in POLR3A and POLR3B encoding RNA polymerase III subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy. Am J Hum Genet 89:644–651PubMedPubMedCentral Saitsu H, Osaka H, Sasaki M, Takanashi J, Hamada K, Yamashita A, Shibayama H, Shiina M, Kondo Y, Nishiyama K, Tsurusaki Y, Miyake N, Doi H, Ogata K, Inoue K, Matsumoto N (2011) Mutations in POLR3A and POLR3B encoding RNA polymerase III subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy. Am J Hum Genet 89:644–651PubMedPubMedCentral
go back to reference Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y, Schalm S, Murias S, Dare JA, Brown D, Stone DL, Gao L, Klausmeier T, Foell D, de Jesus AA, Chapelle DC, Kim H, Dill S, Colbert RA, Failla L, Kost B, O’Brien M, Reynolds JC, Folio LR, Calvo KR, Paul SM, Weir N, Brofferio A, Soldatos A, Biancotto A, Cowen EW, Digiovanna JJ, Gadina M, Lipton AJ, Hadigan C, Holland SM, Fontana J, Alawad AS, Brown RJ, Rother KI, Heller T, Brooks KM, Kumar P, Brooks SR, Waldman M, Singh HK, Nickeleit V, Silk M, Prakash A, Janes JM, Ozen S, Wakim PG, Brogan PA, Macias WL, Goldbach-Mansky R (2018) JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. J Clin Invest 128:3041–3052PubMedPubMedCentral Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y, Schalm S, Murias S, Dare JA, Brown D, Stone DL, Gao L, Klausmeier T, Foell D, de Jesus AA, Chapelle DC, Kim H, Dill S, Colbert RA, Failla L, Kost B, O’Brien M, Reynolds JC, Folio LR, Calvo KR, Paul SM, Weir N, Brofferio A, Soldatos A, Biancotto A, Cowen EW, Digiovanna JJ, Gadina M, Lipton AJ, Hadigan C, Holland SM, Fontana J, Alawad AS, Brown RJ, Rother KI, Heller T, Brooks KM, Kumar P, Brooks SR, Waldman M, Singh HK, Nickeleit V, Silk M, Prakash A, Janes JM, Ozen S, Wakim PG, Brogan PA, Macias WL, Goldbach-Mansky R (2018) JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. J Clin Invest 128:3041–3052PubMedPubMedCentral
go back to reference Sandborn WJ, Su C, Panes J (2017) Tofacitinib as induction and maintenance therapy for ulcerative colitis. N Engl J Med 377:496–497PubMed Sandborn WJ, Su C, Panes J (2017) Tofacitinib as induction and maintenance therapy for ulcerative colitis. N Engl J Med 377:496–497PubMed
go back to reference Schabitz WR, Rogalewski A, Hagemeister C, Bien CG (2014) VZV brainstem encephalitis triggers NMDA receptor immunoreaction. Neurology 83:2309–2311PubMed Schabitz WR, Rogalewski A, Hagemeister C, Bien CG (2014) VZV brainstem encephalitis triggers NMDA receptor immunoreaction. Neurology 83:2309–2311PubMed
go back to reference Schimpff S, Serpick A, Stoler B, Rumack B, Mellin H, Joseph JM, Block J (1972) Varicella-zoster infection in patients with cancer. Ann Intern Med 76:241–254PubMed Schimpff S, Serpick A, Stoler B, Rumack B, Mellin H, Joseph JM, Block J (1972) Varicella-zoster infection in patients with cancer. Ann Intern Med 76:241–254PubMed
go back to reference Schober T, Magg T, Laschinger M, Rohlfs M, Linhares ND, Puchalka J, Weisser T, Fehlner K, Mautner J, Walz C, Hussein K, Jaeger G, Kammer B, Schmid I, Bahia M, Pena SD, Behrends U, Belohradsky BH, Klein C, Hauck F (2017) A human immunodeficiency syndrome caused by mutations in CARMIL2. Nat Commun 8:14209PubMedPubMedCentral Schober T, Magg T, Laschinger M, Rohlfs M, Linhares ND, Puchalka J, Weisser T, Fehlner K, Mautner J, Walz C, Hussein K, Jaeger G, Kammer B, Schmid I, Bahia M, Pena SD, Behrends U, Belohradsky BH, Klein C, Hauck F (2017) A human immunodeficiency syndrome caused by mutations in CARMIL2. Nat Commun 8:14209PubMedPubMedCentral
go back to reference Sen N, Sung P, Panda A, Arvin AM (2018) Distinctive roles for type I and type II interferons and interferon regulatory factors in the host cell defense against varicella-zoster virus. J Virol 12;92(21):e01151–18 Sen N, Sung P, Panda A, Arvin AM (2018) Distinctive roles for type I and type II interferons and interferon regulatory factors in the host cell defense against varicella-zoster virus. J Virol 12;92(21):e01151–18
go back to reference Serac G, Tubach F, Mariette X, Salmon-Ceron D, Ravaud P, Liote F, Laharie D, Ziza JM, Marguerie L, Bonnet C et al (2012) Risk of herpes zoster in patients receiving anti-TNF-alpha in the prospective French RATIO registry. J Invest Dermatol 132:726–729PubMed Serac G, Tubach F, Mariette X, Salmon-Ceron D, Ravaud P, Liote F, Laharie D, Ziza JM, Marguerie L, Bonnet C et al (2012) Risk of herpes zoster in patients receiving anti-TNF-alpha in the prospective French RATIO registry. J Invest Dermatol 132:726–729PubMed
go back to reference Sogaard OS, Lohse N, Ostergaard L, Kronborg G, Roge B, Gerstoft J, Sorensen HT, Obel N (2012) Morbidity and risk of subsequent diagnosis of HIV: a population based case control study identifying indicator diseases for HIV infection. PLoS One 7:e32538PubMedPubMedCentral Sogaard OS, Lohse N, Ostergaard L, Kronborg G, Roge B, Gerstoft J, Sorensen HT, Obel N (2012) Morbidity and risk of subsequent diagnosis of HIV: a population based case control study identifying indicator diseases for HIV infection. PLoS One 7:e32538PubMedPubMedCentral
go back to reference Sokal JE, Firat D (1965) Varicella-zoster infection in Hodgkin’s disease: clinical and epidemiological aspects. Am J Med 39:452–463PubMed Sokal JE, Firat D (1965) Varicella-zoster infection in Hodgkin’s disease: clinical and epidemiological aspects. Am J Med 39:452–463PubMed
go back to reference Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, Arthur DC, Gu W, Gould CM, Brewer CC, Cowen EW, Freeman AF, Olivier KN, Uzel G, Zelazny AM, Daub JR, Spalding CD, Claypool RJ, Giri NK, Alter BP, Mace EM, Orange JS, Cuellar-Rodriguez J, Hickstein DD, Holland SM (2014) GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood 123:809–821PubMedPubMedCentral Spinner MA, Sanchez LA, Hsu AP, Shaw PA, Zerbe CS, Calvo KR, Arthur DC, Gu W, Gould CM, Brewer CC, Cowen EW, Freeman AF, Olivier KN, Uzel G, Zelazny AM, Daub JR, Spalding CD, Claypool RJ, Giri NK, Alter BP, Mace EM, Orange JS, Cuellar-Rodriguez J, Hickstein DD, Holland SM (2014) GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood 123:809–821PubMedPubMedCentral
go back to reference Strangfeld A, Listing J, Herzer P, Liebhaber A, Rockwitz K, Richter C, Zink A (2009) Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA 301:737–744PubMed Strangfeld A, Listing J, Herzer P, Liebhaber A, Rockwitz K, Richter C, Zink A (2009) Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA 301:737–744PubMed
go back to reference Tattevin P, Schortgen F, de Broucker T, Dautheville S, Wolff M (2001) Varicella-zoster virus limbic encephalitis in an immunocompromised patient. Scand J Infect Dis 33:786–788PubMed Tattevin P, Schortgen F, de Broucker T, Dautheville S, Wolff M (2001) Varicella-zoster virus limbic encephalitis in an immunocompromised patient. Scand J Infect Dis 33:786–788PubMed
go back to reference Teo SY, Raha D, Warren D, Hassan A, Monteiro E (2014) Central nervous system-immune reconstitution inflammatory syndrome presenting as varicella zoster virus-mediated vasculitis causing stroke. Int J STD AIDS 25:683–685PubMed Teo SY, Raha D, Warren D, Hassan A, Monteiro E (2014) Central nervous system-immune reconstitution inflammatory syndrome presenting as varicella zoster virus-mediated vasculitis causing stroke. Int J STD AIDS 25:683–685PubMed
go back to reference Thomas SL, Hall AJ (2004) What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 4:26–33PubMed Thomas SL, Hall AJ (2004) What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 4:26–33PubMed
go back to reference Thomas SL, Wheeler JG, Hall AJ (2002) Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 360:678–682PubMed Thomas SL, Wheeler JG, Hall AJ (2002) Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 360:678–682PubMed
go back to reference Tomkins A, Babu C, Herwadkar A, Siripurapu R, McKee D (2018) Varicella zoster virus cerebral aneurysmal vasculopathy presenting in a newly-diagnosed HIV-positive patient. Int J STD AIDS 29:1351–1353PubMed Tomkins A, Babu C, Herwadkar A, Siripurapu R, McKee D (2018) Varicella zoster virus cerebral aneurysmal vasculopathy presenting in a newly-diagnosed HIV-positive patient. Int J STD AIDS 29:1351–1353PubMed
go back to reference van Delden C, Stampf S, Hirsch HH, Manuel O, Meylan P, Cusini A, Hirzel C, Khanna N, Weisser M, Garzoni C et al (2020) Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss transplant cohort study. Clin Infect Dis. https://doi.org/10.1093/cid/ciz1113 van Delden C, Stampf S, Hirsch HH, Manuel O, Meylan P, Cusini A, Hirzel C, Khanna N, Weisser M, Garzoni C et al (2020) Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss transplant cohort study. Clin Infect Dis. https://​doi.​org/​10.​1093/​cid/​ciz1113
go back to reference van der Werff ten Bosch JE, Kollen WJ, Ball LM, Brinkman DM, Vossen AC, Lankester AC, Egeler RM, Bredius RG (2009) Atypical varicella zoster infection associated with hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 53:226–228 van der Werff ten Bosch JE, Kollen WJ, Ball LM, Brinkman DM, Vossen AC, Lankester AC, Egeler RM, Bredius RG (2009) Atypical varicella zoster infection associated with hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 53:226–228
go back to reference Venkataramana A, Pardo CA, McArthur JC, Kerr DA, Irani DN, Griffin JW, Burger P, Reich DS, Calabresi PA, Nath A (2006) Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology 67:383–388PubMed Venkataramana A, Pardo CA, McArthur JC, Kerr DA, Irani DN, Griffin JW, Burger P, Reich DS, Calabresi PA, Nath A (2006) Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology 67:383–388PubMed
go back to reference Whitley RJ, Gnann JW Jr (1995) Herpes zoster in patients with human immunodeficiency virus infection-an ever-expanding spectrum of disease. Clin Infect Dis 21:989–990PubMed Whitley RJ, Gnann JW Jr (1995) Herpes zoster in patients with human immunodeficiency virus infection-an ever-expanding spectrum of disease. Clin Infect Dis 21:989–990PubMed
go back to reference Williamson EM, Berger JR (2015) Central nervous system infections with immunomodulatory therapies. Continuum (Minneap Minn) 21:1577–1598 Williamson EM, Berger JR (2015) Central nervous system infections with immunomodulatory therapies. Continuum (Minneap Minn) 21:1577–1598
go back to reference Winthrop KL, Park SH, Gul A, Cardiel MH, Gomez-Reino JJ, Tanaka Y, Kwok K, Lukic T, Mortensen E, Ponce de Leon D, Riese R, Valdez H (2016) Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis. Ann Rheum Dis 75:1133–1138PubMed Winthrop KL, Park SH, Gul A, Cardiel MH, Gomez-Reino JJ, Tanaka Y, Kwok K, Lukic T, Mortensen E, Ponce de Leon D, Riese R, Valdez H (2016) Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis. Ann Rheum Dis 75:1133–1138PubMed
go back to reference Wolfe F, Michaud K, Chakravarty EF (2006) Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders. Rheumatology (Oxford) 45:1370–1375 Wolfe F, Michaud K, Chakravarty EF (2006) Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders. Rheumatology (Oxford) 45:1370–1375
go back to reference Wood JN, Boorman JP, Okuse K, Baker MD (2004) Voltage-gated sodium channels and pain pathways. J.Neurobiol 61:55–71PubMed Wood JN, Boorman JP, Okuse K, Baker MD (2004) Voltage-gated sodium channels and pain pathways. J.Neurobiol 61:55–71PubMed
go back to reference Wong KK, Hirsch MS (1984) Herpes virus infections in patients with neoplastic disease. Diagnosis and therapy. Am J Med 76:464–478PubMed Wong KK, Hirsch MS (1984) Herpes virus infections in patients with neoplastic disease. Diagnosis and therapy. Am J Med 76:464–478PubMed
go back to reference Yee CS, Massaad MJ, Bainter W, Ohsumi TK, Foger N, Chan AC, Akarsu NA, Aytekin C, Ayvaz DC, Tezcan I et al (2016) Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association. J Allergy Clin Immunol 137(879–888):e872 Yee CS, Massaad MJ, Bainter W, Ohsumi TK, Foger N, Chan AC, Akarsu NA, Aytekin C, Ayvaz DC, Tezcan I et al (2016) Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association. J Allergy Clin Immunol 137(879–888):e872
go back to reference Yeung J, Cauquil C, Saliou G, Nasser G, Rostomashvili S, Adams D, Theaudin M (2013) Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab. Neurology 80:1812–1813PubMedPubMedCentral Yeung J, Cauquil C, Saliou G, Nasser G, Rostomashvili S, Adams D, Theaudin M (2013) Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab. Neurology 80:1812–1813PubMedPubMedCentral
go back to reference Zerboni L, Arvin A (2015) Neuronal subtype and satellite cell tropism are determinants of varicella-zoster virus virulence in human dorsal root ganglia xenografts in vivo. PLoS Pathog 11:e1004989PubMedPubMedCentral Zerboni L, Arvin A (2015) Neuronal subtype and satellite cell tropism are determinants of varicella-zoster virus virulence in human dorsal root ganglia xenografts in vivo. PLoS Pathog 11:e1004989PubMedPubMedCentral
go back to reference Zerboni L, Sen N, Oliver SL, Arvin AM (2014) Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol 12:197–210PubMedPubMedCentral Zerboni L, Sen N, Oliver SL, Arvin AM (2014) Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol 12:197–210PubMedPubMedCentral
go back to reference Zhang N, Wilkinson S, Riaz M, Ostor AJ, Nisar MK (2012) Does methotrexate increase the risk of varicella or herpes zoster infection in patients with rheumatoid arthritis? A systematic literature review. Clin Exp Rheumatol 30:962–971PubMed Zhang N, Wilkinson S, Riaz M, Ostor AJ, Nisar MK (2012) Does methotrexate increase the risk of varicella or herpes zoster infection in patients with rheumatoid arthritis? A systematic literature review. Clin Exp Rheumatol 30:962–971PubMed
go back to reference Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, Matthews HF, Davis J, Turner ML, Uzel G, Holland SM, Su HC (2009) Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 361:2046–2055PubMedPubMedCentral Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, Matthews HF, Davis J, Turner ML, Uzel G, Holland SM, Su HC (2009) Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 361:2046–2055PubMedPubMedCentral
go back to reference Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, Picard C, Chapgier A, Plancoulaine S, Titeux M, Cognet C, von Bernuth H, Ku CL, Casrouge A, Zhang XX, Barreiro L, Leonard J, Hamilton C, Lebon P, Heron B, Vallee L, Quintana-Murci L, Hovnanian A, Rozenberg F, Vivier E, Geissmann F, Tardieu M, Abel L, Casanova JL (2007) TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522–1527PubMed Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, Picard C, Chapgier A, Plancoulaine S, Titeux M, Cognet C, von Bernuth H, Ku CL, Casrouge A, Zhang XX, Barreiro L, Leonard J, Hamilton C, Lebon P, Heron B, Vallee L, Quintana-Murci L, Hovnanian A, Rozenberg F, Vivier E, Geissmann F, Tardieu M, Abel L, Casanova JL (2007) TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522–1527PubMed
Metadata
Title
Determinants of neurological syndromes caused by varicella zoster virus (VZV)
Authors
Peter GE Kennedy
Trine H Mogensen
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
Journal of NeuroVirology / Issue 4/2020
Print ISSN: 1355-0284
Electronic ISSN: 1538-2443
DOI
https://doi.org/10.1007/s13365-020-00857-w

Other articles of this Issue 4/2020

Journal of NeuroVirology 4/2020 Go to the issue